Skip to main content
Log in

MR imaging of head and neck lesions using high-dose gadodiamide injection: a phase III clinical trial

  • Head and Neck Radiology
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

In order to evaluate the safety and efficacy of a high-dose gadodiamide injection a phase-III trial was conducted using a dose of 0.3 mmol Gd/kg bw in patients with known or suspected tumors in the head and neck region. A total of 90 in- and outpatients referred to MR examination for tumor in the head and neck area were included. Precontrast images consisted of T1- and T2-weighted sequences. A FATSAT sequence was also applied. After i. v. contrast administration T1-weighted scans were obtained. Efficacy was evaluated by means of a comparison of the pre- and postcontrast images. Postcontrast images gave more diagnostic information compared with precontrast images, which facilitated diagnosis in all patients. In 8 patients T1-weighted postcontrast images revealed abnormal structures not seen on precontrast images and no lesion was obscured by the contrast medium. Gadodiamide injection at a dose of 0.3 mmol Gd/kg bw was judged as safe and effective for the examination of tumors in the head and neck region. Use of the contrast medium increased the diagnostic information in the images and increased the confidence in making the diagnosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Mikhael MA, Ciric IS, Wolff AP (1985) Differentiation of cerebellopontine angle neuromas and meningiomas with MR imaging. J Comput Assist Tomogr 9: 852–856

    Google Scholar 

  2. Press GA, Hesselink JR (1988) MR imaging of cerebellopontine angle and internal auditory canal lesions at 1.5T. AJNR 8: 241–251

    Google Scholar 

  3. Fürst G, Zamboglou N, Greven C, Kahn T, Modder U (1988) Use of contrast media in magnetic resonance tomography of head and neck tumors. Fortschr Roentgenstr 149: 489–495

    Google Scholar 

  4. Robinson JD, Crawford SC, Teresi LM, Schiller VL, Lufkin RB, Harnsberger HR, Dietrich RB, Crim JR, Duckwiler GR, Spickler EM, Hanafee WN (1989) Extracranial lesions of the head and neck — preliminary experience with GD-DTPA-enhanced MR imaging. Radiology 172: 165–170

    Google Scholar 

  5. Phillips CD, Gay SB, Newton RL, Levine PA (1990) Gadolinium-enhanced MRI of tumors of the head and neck. Head Neck 12: 308–315

    Google Scholar 

  6. Sze G, Zawadzki MB, Haughton VM et al. (1991) Multicenter study of gadodiamide injection as a contrast agent in MR imaging of the brain and spine. Radiology 181: 693–699

    Google Scholar 

  7. Greco A, McNamara MT, Lanthiez P et al (1990) Gadodiamide injection: nonionic gadolinium chelate for MR imaging of the brain and spine — phase II–III clinical trial. Radiology 176: 451–456

    Google Scholar 

  8. Mühler A, Saeed M, Brasch RC, Higgins CB (1992) Haemodynamic effects of gadodiamide injection and gadopentate dimeglumine as contrast media in MR imaging in rats. Radiology 183: 523–528

    Google Scholar 

  9. Geigy Scientific Tables, vol 2, 1982

  10. Haustein J, Laniado M, Niendorf HP et al. (1992) Administration of gadopentetate dimeglumine in MR imaging of intracranial tumors: dosage and field strength. AJNR 13: 1199–1206

    Google Scholar 

  11. Yuh WTC, Fisher DJ, Engelken JD et al. (1991) MR evaluation of CNS tumors: dose comparison study with gadopentetate dimeglumine and gadoteridol. Radiology 180: 485–491

    Google Scholar 

  12. Haustein J, Laniado M, Niendorf HP et al. (1993) Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients. Radiology 186: 855–860

    Google Scholar 

  13. Vogl TJ, Mack MG, Juergens M, Stark M, Pegios W, Bergman C, Grevers G, Western A (1994) MR diagnosis of head and neck tumors: comparison of contrast enhancement with triple-dose gadodiamide and standard-dose gadopentetate Dimeglumine in the same patients. AJR 163: 415–432

    Google Scholar 

  14. Negendank WG, Al-Katib AM, Karanes C, Smith MR (1990) Lymphomas: MR imaging contrast characteristics with clinical-pathologic correlation. Radiology 177: 209–216

    Google Scholar 

  15. Sigal R, Monnet O, Baere T de, Micheau C, Shapeero LG, Julieron M, Bosq J, Vanel D, Piekarski JD, Luboinski B, Masselot J (1992) Adenoid cystic carcinoma of the head and neck: evaluation with MR imaging and clinical-pathologic correlation in 27 patients. Radiology 184: 95–101

    CAS  PubMed  Google Scholar 

  16. Crim JR, Seeger LL, Yao L, Chandnani V, Eckardt JJ (1992) Diagnosis of soft tissue masses with MR imaging: Can benign masses be differentiated from malignant ones? Radiology 185: 581–586

    CAS  PubMed  Google Scholar 

  17. Vogl TJ, Mack MG, Juergens M, Bergman C, Grevers G, Jacobsen TF, Lissner J, Felix R (1993) Skull base tumors: gadodiamide injection-enhanced MR imaging: drop-out effect in the early enhancement pattern of paragangliomas versus different tumors. Radiology 188: 339–346

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vogl, T.J., Western, A., Mack, M.G. et al. MR imaging of head and neck lesions using high-dose gadodiamide injection: a phase III clinical trial. Eur. Radiol. 5, 609–614 (1995). https://doi.org/10.1007/BF00190926

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00190926

Key words

Navigation